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Proteins with RNA chaperone activity are ubiquitous proteins that play important roles in cellular mechanisms. They prevent
RNA from misfolding by loosening misfolded structures without ATP consumption. RNA chaperone activity is studied in vitro
and in vivo using oligonucleotide- or ribozyme-based assays. Due to their functional as well as structural diversity, a common
chaperoning mechanism or universal motif has not yet been identiﬁed. A growing database of proteins with RNA chaperone
activity has been established based on evaluation of chaperone activity via the described assays. Although the exact mechanism
is not yet understood, it is more and more believed that disordered regions within proteins play an important role. This possible
mechanism and which proteins were found to possess RNA chaperone activity are discussed here.
1.Introduction
Among all biological macromolecules, RNAs represent one
of the most functionally versatile players in the cell. RNA
molecules fulﬁll many diﬀerent tasks such as coding and
transfer of genetic information; they play regulatory func-
tions in various cellular processes and catalyze chemical
reactions(likecleavageandligations).Inadditiontoitsfunc-
tional versatility, RNAs are also able to fold into countless
diﬀerent structures, many of which have similar stabilities as
the native structure and therefore compete with the native
fold. Furthermore, RNA molecules often undergo transition
states during their folding pathways before they reach the
native and active structure. These transient structures can
represent traps along the folding pathway from which the
molecules might have a hard time to escape and which then
end up being long-lived intermediates. The reason for this
structural versatility is the fact that RNA consists of only
fourdiﬀerentbaseswhichareeasilycapableofformingstable
helices, that are not necessarily the native structure. The
threshold for RNA molecules to be able to perform their
functionsisusuallytheaccomplishmentofreachingitsnative
and active structure.
In the cellular environment, RNA molecules do not
appear as “naked” nucleic acids but always are found in
conjunction with proteins. In some cases, the RNA molecule
helps the protein partner to fold correctly; in others, the
protein stabilizes the RNA structure. And last but not least
proteins with RNA chaperone activity aid during the folding
process of RNAs. Proteins with RNA chaperone activity
open up misfolded RNA structures and do not require ATP
[1]. Furthermore, after the RNA has been folded into its
native structure, the protein becomes dispensable. Although
the term “RNA chaperone” has been used routinely to
describe various proteins that are capable to assist RNA
folding in vitro, the term RNA chaperone is reserved to
describe proteins whose RNA folding activity has been
veriﬁed on its natural target RNA in vivo. Therefore, most
of the proteins in this paper will be referred to as proteins
with RNA chaperone activity if their RNA folding activity
was only determined in vitro and/ or on nonnatural RNA
targets.
This paper will focus on the diversity of proteins with
RNA chaperone activity and which experimental assays are
in use to determine whether a protein has RNA chaperone
activity. I will present examples for proteins with RNA2 Biochemistry Research International
chaperone activity and discuss possible mechanisms of RNA
chaperoning.
2. The Deﬁnition of Proteinswith RNA
ChaperoneActivityandRNA Misfolding
2.1. What Are RNA Chaperones and Proteins with RNA
Chaperone Activity? The list of proteins with possible RNA
chaperone activity is growing constantly. Proteins with
diﬀerent activities that support RNA folding are classiﬁed in
this group. The deﬁnition of a protein with RNA chaperone
activity is that the protein prevents RNA from misfolding
by opening up misfolded structures. Proteins with RNA
chaperone activity do not require ATP, which distinguishes
them from RNA helicases, another group of proteins that
facilitate RNA folding (e.g., Cyt-19) [2].
Proteins with RNA chaperone activity interact only
transiently with RNA molecules and are supposed to be
dispensable once the RNA has been folded correctly. This
was shown for E. coli proteins S12 and StpA [3, 4]. A
transient interaction and weak binding to RNA might be
diﬃcult to deﬁne because many of the identiﬁed RNA
chaperones interact strongly with their target RNAs and are
found in RNP complexes like ribosomal proteins, hnRNPs,
La protein, and others. However, it has been demonstrated
that a mutant StpA that shows stronger binding towards
RNA shows decreased RNA chaperone activity suggesting
thatstrongbinding couldalsobedetrimentaltoRNAfolding
[5]. In that way, proteins with RNA chaperone activity are
also distinguished from “stabilizers” that are proteins that
bind and stabilize an RNA structure and are required to
stay bound in order to keep the RNA’s native structure.
Cyt-18, the tRNA synthetase from Neurospora crassa,i s
a “stabilizer” for the mitochondrial self-splicing group I
intron: its presence is required to keep the native structure
of the intron which otherwise unfolds readily.
In the growing database of “proteins with RNA chaper-
one activity”, there exists an increasing number of proteins
that simply possess RNA annealing activity. A prominent
and intensively studied member of this group is the bacterial
host factor Hfq that showed annealing activity on random
substrates. Hfq in addition is an RNA chaperone as it
was further demonstrated that Hfq does possess unwinding
a c t i v i t yu p o ni t sn a t i v es u b s t r a t e s[ 6, 7].
In brief, the group of proteins with RNA chaperone
activity includes proteins that, ﬁrst, open up misfolded
structures without requirement of ATP and that, second, are
dispensable once the RNA has been folded.
2.2. RNA Misfolding. RNA molecules are prone to misfold
in vitro and are usually prevented from misfolding in
vivo. RNA basically encounters two folding problems: a
kinetic folding problem, where the RNA molecule has to
surmount kinetic barriers during the search for its native
structure. Secondly, RNA molecules meet a thermodynamic
folding problem as the ﬁnal native structure often has to
compete with alternative folds that have similar energetic
stabilities [1]. RNA folding is a hierarchical process, and
ﬁrst secondary structure elements have to form. Secondary
structural elements form between regions within the RNA
molecule that are in close proximity. They are A-form helices
consisting of Watson-Crick base-pairs. Secondary structures
are very stable. The stability of a base-pair depends on
the stability of both of its neighbouring base-pairs. Already
a n yR N Ao far e a s o n a b l el e n g t hi sa b l et of o r ma l t e r n a t i v e
base-pairs leading to alternative helices that become folding
traps.
Tertiary structures are higher order structures that are
built by assembling the secondary structure elements into
a more complex collapsed fold. They can also involve
formation of helices. This is the case in pseudoknots
where either a loop region interacts with a distant single
stranded region or with another distant loop. Pseudoknots
possess similar stability as secondary structures. But tertiary
structural elements involve also other non-Watson-Crick
interactions where for example, not only the Watson-Crick
site of the nucleotide interacts with another nucleotide but
also the Hoogsteen edge or the sugar edge of the nucleotide
is involved in hydrogen bonding [8]. An often reoccurring
tertiary structure motif is the A-minor interaction where an
adenine interacts with the minor groove of the A-form helix
[9]. Tertiary structures are often less stable and depend on
the formation of secondary structures. Finally, monovalent
or divalent metal ions play an important role in tertiary
structure formation.
The ﬁrststudies on RNA structureand folding weredone
in the 1960s with yeast tRNA molecules. Already then it
was demonstrated that tRNAs are able to adopt two distinct
conformations of which only one is the native structure
which can be aminoacylated [10, 11].
The RNA folding problem becomes even more promi-
nent in the case of large RNAs such as group I introns or in
the context of large protein-ribonucleic acid complexes such
as RNase P and the ribosome.
It was demonstrated that the self-splicing group I intron
of the thymidylate synthase gene of phage T4 misfolds in
the absence of translation: when the ribosome does not
preventbase-pairingbetweenexonandintronsequences,the
intron is not able to fold correctly and cannot perform the
splicing reaction [12]. A similar observation was made with
the group I intron of Tetrahymena thermophila ribosomal
RNA: a subset of molecules misfolds and accumulates into
an inactive population [13]. Misfolding depends on exon
sequences that form stable hairpins and intervene with 5 -
splice-site formation.
In vivo, however, some group I introns require the assis-
tance of proteins to splice eﬃciently and prevent misfolding.
For an example, the Cyt-18 protein in Neurospora crassa
mitochondira is a tRNA synthetase which stabilizes the P4-
P6 domain of group I introns and recruits Cyt-19, an RNA
helicase, which then unwinds folding traps and promotes
splicing [2, 14].
ForlargeRNPcomplexessuchastheribosome,agrowing
body of evidence suggests that several additional factors such
as helicases exist that assist during the folding process in
vivo.Biochemistry Research International 3
3. Assaysto MeasureRNA ChaperoneActivity
As proteins with RNA chaperone activity are very heteroge-
neous concerning their structure and their way to resolve the
folding of RNA molecules, there are various RNA chaperone
assays available to measure diﬀerent activities. In principle,
the assays can be divided into in vitro and in vivo assays that
use either simple oligonucleotide annealing or displacement
reactions or that measure catalytic activities of correctly
folded ribozymes.
Measuringanactivitythatmightbetargetedmorespecif-
ically to a certain subset of substrates in the natural envi-
ronment of the putative RNA chaperone makes it diﬃcult
to evaluate RNA chaperone activity using a single assay. The
substrates in the in vitro assay (e.g., oligonucleotides) might
diﬀer in sequence requirements or structure requirements
from possible native substrates and might lead to negative
results. Strand unwinding assays might give positive results
in the case of single-strand binding proteins. Furthermore,
in vivo assays to measure RNA chaperone activity can be
negativelyinﬂuencedbypossibletoxicityoftheputativeRNA
chaperone when overexpressed or can lead to secondary
eﬀects in the cell that give false positive results. Therefore,
it is recommended to measure the RNA chaperone activity at
least in more than one chaperone assay to be certain that no
non-speciﬁc activity is measured.
3.1. In Vitro RNA Chaperone Activity Assays (see Figure 1)
3.1.1. Oligonucleotide Annealing. In this assay, two comple-
mentary oligonucleotides (oligos) present in concentrations
above their dissociation constant are incubated together in
theabsenceandinthepresenceoftheproteintobeevaluated
for RNA chaperone activity. An increase in the rate of duplex
formation is observed when the tested protein has RNA
annealing activity. In principle two complementary short
RNA oligos are used in this assay, although it has been a
habit to choose DNA oligos instead. In order to measure
RNA chaperone activity, however, I think that RNA oligonu-
cleotides should be the preferred choice. Detection methods
of duplex formation include native gel electrophoresis where
thetwocomplementaryRNAstrandscaneitherbevisualized
by radioactive or ﬂuorophor labelling and has been used
in (besides many many other publications) [15–17]. RNA
annealing can alternatively be measured by observing the
ﬂuorescence resonance energy transfer (FRET) upon the
closing up of the two ﬂuorescently labelled oligonucleotides
(e.g., see [18, 19]).
3.1.2. Oligonucleotide Melting and Strand-Displacement
Activities. The ability of a protein to open up and unwind
an already formed RNA duplex is measured. To measure
RNA chaperone activity in contrast to helicase activity, this
assay is performed in the absence of ATP or an alternative
energy source. Analogous to the annealing assays, melting
activity can be detected by using native gel electrophoresis
or by measuring loss of ﬂuorescence energy resonance
transfer (FRET) that occurs upon dissociation of the
complementary ﬂuorophor labelled RNAs. In addition to
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Figure 1: In vitro chaperone assays. (a) shows a simple annealing
assay where two complementary RNA strands are annealed in
the presence of RNA chaperones. (b) In the strand displacement
assay, the RNA duplex is loosened and an alternative RNA helix
is formed. (c) Hammerhead ribozyme cleavage is enhanced in
the presence of chaperones. Under single turnover conditions,
substrate to ribozyme annealing is measured. Under multiple
turnover conditions substrate dissociation is measured. (d) In the
trans-splicing assay, the group I intron is split in two halves H1
(upstream exon, 5 -part of the intron) and H2 (3 - p a r to ft h e
intron and exon2), and splicing at low temperatures in the presence
of chaperones is measured. (e) shows the cis-splicing assay where
an enhancement of splicing at 37◦C is measured in the presence
of chaperones. The construct (shosho) contains short exon 1 (27
nucleotides) and short exon 2 (2 nucleotides) sequences.
the above-described detection methods, new approaches to
detect folding or unfolding of single molecules emerge and
include time-resolved NMR, which becomes a powerful tool
to study folding of small RNAs.
3.1.3. Hammerhead Ribozyme Cleavage. The hammerhead
ribozyme cleavage reaction and folding of the ribozyme-
substrate 3-way helical junction have been studied in a great
detail. Therefore, this assay represents a suitable tool to study
RNA chaperone activity upon folding of the hammerhead
ribozyme-substrate construct. Using the hammerhead cleav-
age assay, both annealing and strand displacement can be4 Biochemistry Research International
studied independently of each other [3, 20]. The advantage
on the well-studied assay is that depending whether single-
turnover conditions or multiple turnover conditions are
employed,it is possible to distinguish between annealing and
strand dissociation activities. Using single-turnover condi-
tions, where an excess of ribozyme and low concentrations
of substrate are applied, substrate annealing is determined
as substrate annealing becomes the rate limiting step. On
the other hand, using multiple turnover conditions with
an excess of substrate over ribozyme, the whole cleavage
reaction is monitored consisting of annealing and product
release. Since product release represents the rate limiting
step, product dissociation is measured.
3.1.4. Group I Intron Splicing. Self-splicing of the thymidy-
late synthase group I intron (td intron) of bacteriophage
T4 has been characterized, and the td intron has been used
lengthily to monitor RNA chaperone activity of various
proteins. Splicing of diﬀerent group I intron constructs that
do not fold readily into the splicing competent structure in
vitro is tested with and without chaperones.
Cis-Splicing Assay. In this td intron construct both, 5  and
3  exons are shortened for the upstream exon down to 27
nucleotides and the downstream exon shortened to only 2
nucleotides. This short exon construct (td shosho) splices
at 37◦C but RNA chaperones increase folding and as a
consequence the splicing rate of the short-exon construct is
increased as well [5].
Trans-Splicing Assay. Here, the td intron is split into two
halves in the center of loop L6 in the P4-P6 domain,
where in the wild type group I intron an open reading
frame for an endonuclease is present. The upstream in
vitro transcribed construct contains 549 nucleotides of
exon1 and 131 nucleotides of the 5 -part of the intron.
The downstream construct consists of the remaining 147
nucleotides of the intron and 23 nucleotides of exon2.
Correct and eﬃcient folding of the trans-intron-constructs
is signiﬁcantly impaired at 37◦C but works ﬁne at elevated
temperatures (55◦C), which is monitored through splicing
[21]. Chaperones with strong annealing and unwinding
activities such as ribosomal protein L1 or L19 from E. coli
are capable to catalyze trans-splicing at 37◦Co re v e na t
lower temperatures, for example, hnRNPI increases splicing
at 25◦C[ 22].
3.2. In Vivo RNA Chaperone Activity Assays (see Figure 2)
3.2.1. In Vivo Folding Trap Assay in E. coli. Splicing of the
groupIintronwithinthethymidylate synthasegeneofphage
T4 occurs eﬃciently in vivo. Though, when splicing and
translation are uncoupled by introducing stop codons in
the upstream exon, splicing is signiﬁcantly reduced. This
is due to alternative base-pairing of exonic and intronic
sequences which prevent the formation of the intron’s native
fold [12]. The mutant td precursor construct tdSH1 consists
of an exonic stop codon and has an additional intronic
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Figure 2: In vivo chaperone assays. (a–c) show the in vivo folding
trapassay:(a)Inthepresenceoftranslation,thegroupIintronfolds
correctly. (b) In the absence of translation, misfolding of the group
I intron occurs. (c) Proteins with RNA chaperone activity loosen
misfolded structures and splicing can proceed. (d–e) show the
in vivo antitranscription termination assay. (d) The transcription
terminator stem folds and transcription of the chloramphenicol
acetyl transferase cannot proceed. Thus, cells are chloramphenicol
sensitive. (e) Proteins with RNA chaperone activity loosen the
terminator stem, transcription can occur, and the cells become
chloramphenicol resistant.
point mutation (C865U) which further destabilizes the
native intron structure. The tdSH1 construct is signiﬁcantly
impaired in splicing in vivo. Overexpression of RNA chaper-
ones in the presence of the tdSH1 mutant is used to evaluate
if the RNA chaperone is able to rescue the misfolded intron
and restore splicing [23].
3.2.2. Transcription Antitermination Assay in E. coli. Tran-
scription read-through of the chloramphenicol acetylBiochemistry Research International 5
transferase gene (cat) is inhibited due to the preceding
transcription terminator stem. The stable hairpin secondary
structure of the terminator inhibits the polymerase to tran-
scribe the cat gene and as a consequence no chalorampheni-
col resistance is achieved. The cells are chaloramphenicol
(Cm) sensitive. Proteins with RNA chaperone activity are
able to melt the terminator stem and as a consequence
read-through occurs and the cells become chloramphenicol
resistant. The transcription antitermination assay was used
for assaying cold shock proteins or IF1 from E. coli [24–26].
4. ProteinswithRNA ChaperoneActivity
Proteins that possess RNA chaperone activity are very divers
and span from viral to bacterial and human proteins that
are involved in many diﬀerent cellular processes. The list
of RNA chaperones is permanently growing. Recently, a
database for proteins with RNA chaperone activity was
established where every lab is able to contribute their
data for a newly identiﬁed chaperone http://www.projects
.mfpl.ac.at/rnachaperones/index.html [27]. The following
selection of proteins with RNA chaperone activity is not
complete but points out the most important groups or single
proteins.
4.1. Virus-Encoded RNA Chaperones. The ﬁrst viral RNA
chaperone activities were reported in the early 1990s and
showed that nucleocapsid protein 7 (Ncp7) of HIV increases
hammerhead ribozyme cleavage signiﬁcantly [20, 28]. Only
a few years later, another virus-encoded protein with RNA
chaperone activity has been identiﬁed, the HDV delta
antigen, which was also monitored in the hammerhead
ribozyme assay and furthermore shown to be dispensable
after folding has occurred [29].
Flaviviridae core proteins were also monitored and
shown to possess RNA chaperone activity in a hammerhead
cleavage assay and/or RNA strand annealing activities [30,
31]. Interestingly, many of the viral proteins show excep-
tional high degree of disorder. In the case of the Flaviviridae
core proteins, it was also reported that heat denaturation still
retained strand annealing activity suggesting that the disor-
dered domains of the proteins are involved in chaperoning.
Nucleocapsid proteins from two members of the Coro-
naviridae family have been investigated and hammerhead
ribozyme cleavage was shown to be enhanced in their
presence [32, 33]. And again both nucleocapsid proteins
show a high degree of disorder in in silico predictions.
A growing body of evidence suggests that there exist
many more viral proteins that possess RNA chaperone
activity. The list here is not complete but proteins that were
shown to have only DNA annealing activities were left out
in this list. The majority of these small viral proteins show
strong propensity for disorder which suggests that disorder
might be a mechanistic requirement for chaperoning.
Interestingly, studies on Nc proteins demonstrated that
these proteins not only possess RNA chaperone activity in
vitro but also are required for strand annealing and strand
displacement activities on their target RNAs in vivo [33].
Recently, a speciﬁc template switching assay designed to
study strand displacement in a retroviral-derived system
demonstrated that nucleocapsid protein from Coronavirus
shows RNA chaperone activity and most likely is an RNA
chaperone in vivo [34].
4.2. StpA. The E. coli transcriptional regulator StpA, a 15kD
basic protein, was isolated as a repressor of a splicing-
deﬁcient group I intron in thymidylate synthase of phage
T4 [4]. StpA was furthermore shown to possess strong RNA
chaperone activity in vivo in the folding trap assay [35].
The protein was tested in vitro in a strand-annealing and
strand-displacement assay and exhibited strong activities in
both tests [36]. More detailed studies on StpA revealed that
the protein binds transiently to RNA with a preference for
unstructured regions and that binding to RNA is diminished
in the presence of high ionic strength [5]. In an elaborate
study applying in vivo DMS modiﬁcations to the RNA, in
vivo folding of the group I intron was evaluated in the
absence and presence of StpA [37]: Schroeder and coworkers
demonstrated that StpA opens up tertiary interactions of the
td group I intron. While the loosening eﬀect is advantageous
in wild type or misfolded introns, overexpression of StpA in
the presence of introns that were already destabilized in their
3D structure was detrimental. Structure prediction of StpA
suggested that this protein exhibits more than 70% disorder
anditwassuggestedthatthisunfoldedregionsofStpAmight
play a role in chaperoning [38].
4.3. Ribosomal Proteins. Ribosomal proteins are required
within every cellular organism to build up the bacterial
70S or the eukaryal 80S ribosome. Many ribosomal pro-
teins further regulate transcription or translation of their
own operons. In addition, ribosomal proteins are also
involvedinvariousverydiﬀerentcellularprocessesandfulﬁll
extraribosomal functions [39, 40]. Ribosomal proteins are
highlyconservedamongvariousspeciesandmanyribosomal
proteins have unusual long unstructured extensions that
wind their way through the ribosome [41].
The ﬁrst observation that ribosomal proteins are capable
of chaperoning RNA folding came from the Belfort lab:
screening for cellular factors that increase trans-splicing of
the thymidylate synthase group I intron revealed that many
ribosomal proteins possess chaperoning activity, with ribo-
somal protein S12 from the small ribosomal subunit having
the strongest activity [3]. Furthermore, S12 signiﬁcantly
increased hammerhead ribozyme cleavage [3]. A systematic
study on large ribosomal subunit proteins from E. coli
showed that 1/3 of the tested proteins possesses strong RNA
chaperone activity in vitro in the trans-splicing assay [21].
In addition, ribosomal protein L1 orthologs from eukarya,
bacteria, and mesophilic archaea also exhibited strong trans-
splicing and cis-splicing activities in vitro [42]. Although it
makes sense that the RNA chaperone activity of ribosomal
proteins could play a role during ribosome assembly, a
deﬁnite proof for the requirement of this activity in vivo has
not yet been provided. Recently, it was demonstrated that E.
coli ribosomal proteins L15, L16, L18, and L19, that showed6 Biochemistry Research International
RNA chaperone activity in vitro, further possess protein
chaperone activity comparable to other protein chaperones
such as Hsp90 [43]. It was suggested that intrinsically
unstructured domains of ribosomal proteins could play a
role in chaperoning. The exact mechanism, however, still
remains elusive (see Section 5).
4.4. Cold Shock Proteins and IF1. Cold shock proteins (csps)
are conserved throughout bacteria and plants. They are
expressed during cold-shock, when misfolding of RNAs
becomes a major problem for the organism and function
as transcriptional antiterminator at low temperature. Many
experimentsthathavebeenperformedtodescribechaperone
activity of cold-shock proteins utilize DNA helices (and
only sometimes in addition RNA duplexes) and refer to the
activity as nucleic acid melting activity. However, it has to
be mentioned that there are no elaborate studies on whether
there is a diﬀerence between RNA duplex and DNA duplex
melting and whether DNA melting activity automatically is
the same as RNA melting.
E.colicontainsninemembersofthecspfamilyandCspA,
the major cold-shock protein and CspE were identiﬁed to
interact non-speciﬁcally with RNA molecules and to possess
nucleic acid melting activities [44–46].
Cold-shock proteins in higher plants are highly con-
served. Glycine-rich and Zn-ﬁnger containing proteins from
Arabidopsis thaliana have been monitored for their nucleic
acid melting activity, and it was shown that GRP7 (glycine-
rich protein) and CSDP1 (cold shock domain protein)
possess RNA chaperone activity [47]. A recent study also
demonstrated that out of six glycine-rich proteins in rice
(Oryza sativa), which are likely to be involved in adaptation
to cold-shock, three of them exhibit RNA- (and DNA-)
melting activities suggesting that GRPs in plants fulﬁll a
chaperoning role during low temperatures [48].
In E. coli translation, initiation factor 1 (IF1) is a small
71 amino-acid long peptide, which contains 5 rigid β-barrels
and belongs to the OB (oligomer-binding)-fold proteins
such as the cold shock proteins. N- and C-termini of IF1
are highly ﬂexible. It was demonstrated that E. coli IF1
is capable of complementing for a cspB and cspC double
knock-out in Bacillus subtilis suggesting that IF1 and csps
have at least partially overlapping activities [49]. E. coli IF1
exhibits RNA chaperone activity in various assays including
RNA annealing of complementary oligonucleotides, trans-
splicing, in vivo folding trap assay, and transcription anti-
termination in vivo and in vitro [25, 50].
4.5. hnRNPs and Human La Protein. Heteronuclear Ribonu-
cleoproteins encompass a group of about 20 polypeptides
that are predominantly nuclear in localization and are
involved in RNA processing.
The ﬁrst observation that hnRNPs possess RNA chaper-
one activity came in the early 1990s when fractionated HeLa
nuclear extract was tested for annealing activity of an mRNA
and its antisense partner. Three proteins, hnRNP A1, C1
and U, were identiﬁed and hnRNP A1 was further shown
to enhance hammerhead ribozyme cleavage in vitro [16, 20].
Later, a detailed study on possible functions of Ro RNPs,
which are Ro ribonucleoprotein complexes, composed of a
small noncoding cytoplasmic RNA, termed Y RNA and its
protein partners was conducted: besides the permanently
associated proteins Ro60 and La, subpopulations of Ro-
RNPs also contain hnRNP I and hnRNP K, both of which
exhibitedstrongRNAchaperoneactivityinvitrointhetrans-
splicing and the cis-splicing assay [22]. hnRNP I is identical
to poly-pyrimidine binding protein (PTB) isoform 4 and
was identiﬁed as a splicing suppressor in mammalian cells
[51]. It regulates cap-independent translation, localization
of cytoplasmic RNAs, and poly-A-site cleavage [52]. PTB
belongs to the IRES transacting factors (ITAFs), which are
host factors (like La, hnRNP K, nucleolin, unr and many
others) that interact with viral RNAs and induce conforma-
tional changes that then lead to translation initiation [53].
It was further reported that calcivirus replication requires
PTB but only at lower or at higher temperatures than the
permissive 37◦C, suggesting a chaperoning role of PTB [54].
Members of the group of ITAFs have been implicated in
RNA chaperoning like unr, a cold-shock domain containing
protein [55], human La protein, and hnRNP K [22].
HnRNP K is also a multifunctional protein that is
a transcriptional factor for c-myc and c-src [56–58]; it
enhances splicing [59] and is a translational regulator [60].
La proteins primarily bind RNA polymerase III tran-
scripts and protect them from nuclease attack [61]. They
also interact with pre-tRNAs at their UUU-3 OH ends and
facilitate their maturation. La contributes to assembly of
RNP complexes by retaining RNAs in the nucleus. La is
also involved in translation regulation. And human La was
demonstrated to possess RNA chaperone activity in vitro in
the cis-splicing assay and in vivo in the folding trap assay
[22].
4.6.Hfq. ThebacterialproteinHfqwasﬁrstdiscoveredinthe
end 1960s as a host factor for bacteriophage Qβ replication
[62]. The bacterial protein is a pleiotropic regulator for gene
expression in bacteria. It interacts with many small RNAs
and their mRNA targets and regulates posttranscriptional
regulation of small noncoding RNAs such as DsrA, sodB,
oxyS, rprA, and spot42 [63–67]. Hfq preferentially binds to
A/U rich, unstructured regions.
Hfq encompasses an Sm-domain, which is highly con-
served among various species and usually is found in
eukaryotic spliceosomal RNPs. Crystallographic studies of
Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus
aureus Hfq proteins showed that Hfq forms homohexameric
ring structures with a central cationic pore that forms the
RNA binding site [68–70].
Using strand annealing and strand melting assays to
measure RNA chaperone activity of Hfq, only strand anneal-
ing activity was observed [27] .H o w e v e r ,ad e t a i l e ds t u d y
using RNase footprinting on Hfq’s interaction with its target
RNAs sodB mRNA and the small noncoding regulator ryhB
RNA demonstrated that Hfq indeed did loosen secondary
structures within sodB mRNA that lead to binding of its
regulatory RNA rhyB [7]. A similar observation was madeBiochemistry Research International 7
using ﬂuorescence labelled rpoS mRNA and dsrA small
noncoding RNA [6]. By means of FRET, it was shown that
Hfq induces annealing of dsrA to rpoS mRNA and prior to
the annealing event Hfq disrupts rpoS secondary structure
elements. Consequently, Hfq is entitled to be called RNA
chaperone.
4.7. Human Chaperones in Disease
4.7.1. Prion Protein. The prion protein is a misfolded
isoform of the essential component of prion diseases such
as Creutzfeldt-Jakob disease in humans—one of several
neurodegenerative diseases. The function of the human
prion protein is not clearly understood. It was demonstrated
thattheprionproteinhasRNA(andDNA)annealingactivity
[71]; however, it was not yet shown if it possesses also
RNA unwinding activity and may therefore be classiﬁed as
an “annealer”. Interestingly, the prion protein contains an
intrinsically unstructured N-terminal domain [72].
4.7.2. Fragile X Mental Retardation Protein (FMRP). The
fragile X mental retardation protein (FMRP) is linked to the
fragile X syndrome as the disease is due to transcriptional
silencing of the gene. FMRP possesses RNA binding activity
and its interaction partners include a large number of
mRNAs, microRNAs, siRNAs, and small noncoding RNAs
as well as a multitude of diﬀerent proteins [73–76]. It was
demonstrated using hammerhead ribozyme cleavage that
FMRP possesses RNA chaperone activity [77]. And ﬁnally
in line with many other proteins with RNA chaperone
activity, it is interesting to mention that FMRP consists of a
highly disordered C-terminus suggesting that the substrate
versatility of FMRP might be accomplished through its
structural disorder [78].
5.Mechanisms
Chaperones provide a critical cellular activity. Proteins with
RNA chaperone activity are very divers in structure as well as
in function: StpA, a transcriptional activator and repressor
of a multitude of bacterial genes, is a small (15kD) bacterial
protein with intrinsically unstructured regions. StpA has
strong RNA chaperone activity. On the other hand the
bacterialproteinHfqisalargemultidomainproteincomplex
(60kD) and folds into a compact ring-like structure. Among
ribosomal proteins, many were shown to possess RNA
chaperone activity (e.g., one third of large ribosomal subunit
proteins from Escherichia coli show RNA chaperone activity
in vitro). Ribosomal proteins are usually small proteins many
of which have long unstructured domains and are highly
basic proteins.
Proteins with RNA chaperone activity do not require
an external energy source as RNA helicases do. This raises
the question of how RNA chaperones accomplish the RNA
folding task and where the energy for this process comes
from. Proteins with RNA chaperone activity in most cases
encompass two major activities: the annealing activity and
the unwinding activity (see also Figure 3). Many proteins
RNA chaperone
Unfolded
Partially folded
Folded
(a)
RNA chaperone
Unfolded
Partially folded
Folded
Folding trap
(b)
Figure 3: Hypothetical mechanisms of RNA chaperoning. (a) shows
folding of an RNA molecule in the presence of RNA chaperones
(blue). RNA chaperones and proteins with RNA chaperone activity
prevent the RNA from misfolding and increase annealing of the
correct structure by crowding. (b) Proteins with RNA chaperone
activity possessing disordered regions (blue) interact with mis-
folded RNA. Upon energy transfer, the RNA structure loosens and
the disordered protein domain becomes more ordered. Proteins
with RNA chaperone activity are dispensable in both cases after the
RNA has folded into its native form.
with RNA chaperone activity are highly basic proteins
and therefore interact readily with negatively charged RNA
molecules. In that way, they might stabilize folded states by
bringing together distant regions of the RNA molecule and
as a consequence increase RNA double-strand formation.
This mechanism could be comparable to the action of
chemical chaperones such as osmolytes which are small
organic compounds, that do not interfere with the cellular
metabolism but speed up folding processes enabled through
a crowding eﬀect [79].
Another indication that a crowding eﬀect might play a
role at least to some extent during RNA annealing is the
following:whenRNAchaperoneactivityismeasuredinvitro,
there is always an excess of protein over RNA present in the
assay. For example, in the trans-splicing assay, 200 nMols
of RNAs (leading to a 20nM end-concentration) are tested
for folding in the presence of 1-2μM protein. It was shown
that E. coli ribosomal protein L1 displays maximal RNA
chaperone activity starting from 400nM up to 2μMp r o t e i n
concentration [42]. This means that at least a 20-fold excess
of protein to RNA has to be present to achieve maximal
chaperoning activity of ribosomal protein L1 from E. coli.
In this line, it also has to be mentioned that in the
in vivo chaperone assay, which uses the folding trap of a
misfolded group I intron in the thymidylate synthase gene
of phage T4, it is always necessary that the measured protein
is overexpressed and available in higher concentrations [23].
For example, the E. coli protein StpA, which is found
constitutively expressed in the bacterial cell, only shows its
RNA chaperone activity in vivo when StpA is additionally
over-expressed from an expression vector, thus showing
that the cellular concentration of StpA is not suﬃcient to
increase folding of the misfolded group I intron. Certainly,
this observation might be due to the engagement of StpA
in other regulatory functions in the bacterial cell; however,
it also points to the direction that more than one molecule8 Biochemistry Research International
of StpA is required to assist folding of the td group I
intron. As a consequence the question rises if and how it
is possible to distinguish between RNA chaperone activity
and a nonspeciﬁc single-strand RNA binding activity of the
proteinthatmightbothpreventmisfolding.Usingthe invivo
folding trap assay, however, not only proteins with possible
RNA chaperone activity like StpA had been tested but also
a viral single strand binding protein from Inﬂuenza virus
(NP) was tested and did not show any increase in splicing
suggesting that single strand RNA binding might not be
suﬃcient for chaperoning. Furthermore, a detailed study on
StpA wild type and mutants demonstrated that only the full-
length StpA was able to show RNA chaperone activity by
simultaneously interacting with two RNA molecules [5].
RNA chaperone activity of StpA has been studied for
morethanadecade.ItwasshownthatStpAhasstronginvivo
and in vitro RNA chaperone activities. In a mechanistical in
vivo study of StpA, Schroeder and coworkers demonstrated
that StpA loosens tertiary contacts within the thymidylate
synthase group I intron [37]. In contrast, the Neurospora
crassa tRNA synthetase Cyt-18 that also increases group I
intron splicing of td stabilizes tertiary interactions. But how
is the opening of tertiary structure elements accomplished
without the hydrolysis of ATP? This strand unwinding
activity is more diﬃcult to explain as the question remains
of how a protein can actively open up hydrogen bonds when
no apparent source of energy is required.
In the protein world, it became more and more visible
that the classical structure-function paradigm does not
necessarily hold for many proteins and their activities. A
growing body of evidence suggests that a multitude of
proteins do not fold into compact domains but are fully
or at least partially unstructured [80]. In eukaryotes, for
example, conservative estimations point out that 5%–15%
of all proteins are completely disordered and 50% of the
cellular proteins have at least long unstructured domains.
An interesting study by Tompa and Csermely demonstrated
that among chaperones a signiﬁcantly high percentage of
proteins show long unstructured regions [38]. Among RNA
chaperones, the percentage of at least partially disordered
proteins is even higher (54%) than in the group of protein
chaperones (36.7%). Disordered proteins and protein seg-
ments allow a broad versatility for interaction partners and
in this case for interaction with diﬀerent RNA molecules.
But it can also explain the ability of proteins with RNA
chaperone activity to multitask as so far no RNA chaperone
has been identiﬁed whose only task is to aid in RNA
folding.Interestingly,itwasrecentlydemonstratedthatsome
ribosomal proteins that possess RNA chaperone activity and
contain disordered regions are also capable to chaperone
proteinfoldingsuggestingonceagainthatdisorderedregions
provide high versatility for substrate interactions [43].
The idea of disordered RNA chaperones is especially
attractive because there are many advantages of proteins
with disordered regions over compact proteins: (1) the main
advantage of a disordered region is that it can easily interact
with a range of many diﬀerent partners and is not limited to
a single binding pocket or recognition element on a partner
molecule. (2) The bigger surface of the unstructured protein
might provide a “loosening eﬀect” for the incorrectly folded
RNA molecule. (3) The troublesome question of where the
energy for the RNA unwinding might come from could be
explained by the gain of compactness upon interaction with
the RNA and a simultaneous loosening of the RNA structure
(see Figure 3(b)). As a consequence, the RNA gains another
chance to fold correctly. (4) The intrinsically unstructured
protein might provide a folding platform for the RNA as the
chaperone holds the RNA molecule in close proximity.
6. Outlook
In future the research focus on RNA chaperones will lie
on the understanding of the molecular mechanism and
how intrinsically unstructured regions in proteins might
play a role in function. Interestingly, two very closely
related ribosomal proteins L1 from Archaea, that encom-
pass 70% aminoacid identity, possess opposite activities:
the mesophilic L1 protein displays strong RNA chaperone
activity whereas the thermophilic one inhibits ribozyme
assays [42]. A detailed mutation study will likely shed light
on the diﬀerent activities and explain the RNA chaperoning
mechanism at least for a subgroup of RNA chaperones.
The big challenge, however, will be to identify in vivo
targets of RNA chaperones. RNA chaperones are evaluated
in assays for their broad speciﬁcity but in vivo they might
be specialized to supervise folding of only a subset of RNA
molecules. The speciﬁcity might possibly be conferred by a
diﬀerent domain than the chaperoning activity.
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